BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 35563820)

  • 1. IFN-γ and TNF Induce Senescence and a Distinct Senescence-Associated Secretory Phenotype in Melanoma.
    Homann L; Rentschler M; Brenner E; Böhm K; Röcken M; Wieder T
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct phenotypes and 'bystander' effects of senescent tumour cells induced by docetaxel or immunomodulatory cytokines.
    Sapega O; Mikyšková R; Bieblová J; Mrázková B; Hodný Z; Reiniš M
    Int J Oncol; 2018 Nov; 53(5):1997-2009. PubMed ID: 30226595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway.
    Sun X; Shi B; Zheng H; Min L; Yang J; Li X; Liao X; Huang W; Zhang M; Xu S; Zhu Z; Cui H; Liu X
    Cell Death Dis; 2018 Feb; 9(3):260. PubMed ID: 29449532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear Translocation of Argonaute 2 in Cytokine-Induced Senescence.
    Rentschler M; Chen Y; Pahl J; Soria-Martinez L; Braumüller H; Brenner E; Bischof O; Röcken M; Wieder T
    Cell Physiol Biochem; 2018; 51(3):1103-1118. PubMed ID: 30476917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Induction of robust senescence-associated secretory phenotype in mouse NIH-3T3 cells by mitomycin C].
    Huang WX; Guo XX; Peng ZZ; Weng CL; Huang CY; Shi BY; Yang J; Liao XX; Li XY; Zheng HL; Liu XG; Sun XR
    Sheng Li Xue Bao; 2017 Feb; 69(1):33-40. PubMed ID: 28217805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Regulators of the Senescence-Associated Secretory Phenotype During Senescence and Aging.
    Han X; Lei Q; Xie J; Liu H; Li J; Zhang X; Zhang T; Gou X
    J Gerontol A Biol Sci Med Sci; 2022 Nov; 77(11):2207-2218. PubMed ID: 35524726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inorganic arsenic exposure-induced premature senescence and senescence-associated secretory phenotype (SASP) in human hepatic stellate cells.
    Okamura K; Sato M; Suzuki T; Nohara K
    Toxicol Appl Pharmacol; 2022 Nov; 454():116231. PubMed ID: 36089002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the Contribution of NF-κB in the Regulation of Chemotherapy-Induced Cell Senescence by Establishing a Tetracycline-Regulated Cell System.
    Pacifico F; Crescenzi E; Leonardi A
    Methods Mol Biol; 2021; 2366():193-212. PubMed ID: 34236640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitofusin 1 silencing decreases the senescent associated secretory phenotype, promotes immune cell recruitment and delays melanoma tumor growth after chemotherapy.
    Tarallo D; Martínez J; Leyva A; Mónaco A; Perroni C; Tassano M; Gambini JP; Cappetta M; Durán R; Moreno M; Quijano C
    Sci Rep; 2024 Jan; 14(1):909. PubMed ID: 38195762
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Zhang JW; Zhang D; Yin HS; Zhang H; Hong KQ; Yuan JP; Yu BP
    Gut Microbes; 2023; 15(1):2197836. PubMed ID: 37017266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitive detection and monitoring of senescence-associated secretory phenotype by SASP-RAP assay.
    Gu L; Kitamura M
    PLoS One; 2012; 7(12):e52305. PubMed ID: 23272236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic and scalable assessment of the senescence-associated secretory phenotype (SASP).
    Malaquin N; Rodier F
    Methods Cell Biol; 2024; 181():181-195. PubMed ID: 38302239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palbociclib-Induced Cellular Senescence Is Modulated by the mTOR Complex 1 and Autophagy.
    Cayo A; Venturini W; Rebolledo-Mira D; Moore-Carrasco R; Herrada AA; Nova-Lamperti E; Valenzuela C; Brown NE
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer.
    Chambers CR; Ritchie S; Pereira BA; Timpson P
    Mol Oncol; 2021 Dec; 15(12):3242-3255. PubMed ID: 34137158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sub-lethal doses of chemotherapeutic agents induce senescence in T cells and upregulation of PD-1 expression.
    Kasamatsu T; Awata-Shiraiwa M; Ishihara R; Murakami Y; Masuda Y; Gotoh N; Oda T; Yokohama A; Matsumura I; Handa H; Tsukamoto N; Murakami H; Saitoh T
    Clin Exp Med; 2023 Oct; 23(6):2695-2703. PubMed ID: 36913034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapeutic HCW9218 augments anti-tumor activity of chemotherapy via NK cell-mediated reduction of therapy-induced senescent cells.
    Chaturvedi P; George V; Shrestha N; Wang M; Dee MJ; Zhu X; Liu B; Egan J; D'Eramo F; Spanoudis C; Gallo V; Echeverri C; You L; Kong L; Fang B; Jeng EK; Rhode PR; Wong HC
    Mol Ther; 2022 Mar; 30(3):1171-1187. PubMed ID: 35051615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy of lymphoma by immune checkpoint inhibitors: the role of T cells, NK cells and cytokine-induced tumor senescence.
    Ahmetlic F; Fauser J; Riedel T; Bauer V; Flessner C; Hömberg N; Hennel R; Brenner E; Lauber K; Röcken M; Mocikat R
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33441389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Techniques to Induce and Quantify Cellular Senescence.
    Noren Hooten N; Evans MK
    J Vis Exp; 2017 May; (123):. PubMed ID: 28518126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Senescent Secretome of Blind Mole Rat
    Odeh A; Eddini H; Shawasha L; Chaban A; Avivi A; Shams I; Manov I
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-TNF-α treatment modulates SASP and SASP-related microRNAs in endothelial cells and in circulating angiogenic cells.
    Prattichizzo F; Giuliani A; Recchioni R; Bonafè M; Marcheselli F; De Carolis S; Campanati A; Giuliodori K; Rippo MR; Brugè F; Tiano L; Micucci C; Ceriello A; Offidani A; Procopio AD; Olivieri F
    Oncotarget; 2016 Mar; 7(11):11945-58. PubMed ID: 26943583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.